BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

217 related articles for article (PubMed ID: 18625706)

  • 1. Transgenic overexpression of Hdac3 in the heart produces increased postnatal cardiac myocyte proliferation but does not induce hypertrophy.
    Trivedi CM; Lu MM; Wang Q; Epstein JA
    J Biol Chem; 2008 Sep; 283(39):26484-9. PubMed ID: 18625706
    [TBL] [Abstract][Full Text] [Related]  

  • 2. CaMKII exacerbates heart failure progression by activating class I HDACs.
    Zhang M; Yang X; Zimmerman RJ; Wang Q; Ross MA; Granger JM; Luczak ED; Bedja D; Jiang H; Feng N
    J Mol Cell Cardiol; 2020 Dec; 149():73-81. PubMed ID: 32971072
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Casein kinase-2α1 induces hypertrophic response by phosphorylation of histone deacetylase 2 S394 and its activation in the heart.
    Eom GH; Cho YK; Ko JH; Shin S; Choe N; Kim Y; Joung H; Kim HS; Nam KI; Kee HJ; Kook H
    Circulation; 2011 May; 123(21):2392-403. PubMed ID: 21576649
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Activation of histone deacetylase 2 by inducible heat shock protein 70 in cardiac hypertrophy.
    Kee HJ; Eom GH; Joung H; Shin S; Kim JR; Cho YK; Choe N; Sim BW; Jo D; Jeong MH; Kim KK; Seo JS; Kook H
    Circ Res; 2008 Nov; 103(11):1259-69. PubMed ID: 18849323
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Hdac2 regulates the cardiac hypertrophic response by modulating Gsk3 beta activity.
    Trivedi CM; Luo Y; Yin Z; Zhang M; Zhu W; Wang T; Floss T; Goettlicher M; Noppinger PR; Wurst W; Ferrari VA; Abrams CS; Gruber PJ; Epstein JA
    Nat Med; 2007 Mar; 13(3):324-31. PubMed ID: 17322895
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Transgenic overexpression of active HDAC4 in the heart attenuates cardiac function and exacerbates remodeling in infarcted myocardium.
    Zhang LX; Du J; Zhao YT; Wang J; Zhang S; Dubielecka PM; Wei L; Zhuang S; Qin G; Chin YE; Zhao TC
    J Appl Physiol (1985); 2018 Dec; 125(6):1968-1978. PubMed ID: 30284520
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Histone deacetylases 1 and 2 redundantly regulate cardiac morphogenesis, growth, and contractility.
    Montgomery RL; Davis CA; Potthoff MJ; Haberland M; Fielitz J; Qi X; Hill JA; Richardson JA; Olson EN
    Genes Dev; 2007 Jul; 21(14):1790-802. PubMed ID: 17639084
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Role of Ca2+/calmodulin-stimulated cyclic nucleotide phosphodiesterase 1 in mediating cardiomyocyte hypertrophy.
    Miller CL; Oikawa M; Cai Y; Wojtovich AP; Nagel DJ; Xu X; Xu H; Florio V; Rybalkin SD; Beavo JA; Chen YF; Li JD; Blaxall BC; Abe J; Yan C
    Circ Res; 2009 Nov; 105(10):956-64. PubMed ID: 19797176
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Suppression of class I and II histone deacetylases blunts pressure-overload cardiac hypertrophy.
    Kong Y; Tannous P; Lu G; Berenji K; Rothermel BA; Olson EN; Hill JA
    Circulation; 2006 Jun; 113(22):2579-88. PubMed ID: 16735673
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cardiac hypertrophy and histone deacetylase-dependent transcriptional repression mediated by the atypical homeodomain protein Hop.
    Kook H; Lepore JJ; Gitler AD; Lu MM; Wing-Man Yung W; Mackay J; Zhou R; Ferrari V; Gruber P; Epstein JA
    J Clin Invest; 2003 Sep; 112(6):863-71. PubMed ID: 12975471
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Selective inhibition of HDAC2 by magnesium valproate attenuates cardiac hypertrophy.
    Raghunathan S; Goyal RK; Patel BM
    Can J Physiol Pharmacol; 2017 Mar; 95(3):260-267. PubMed ID: 28177689
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Angiotensin II induces cardiomyocyte hypertrophy probably through histone deacetylases.
    Lu Y; Yang S
    Tohoku J Exp Med; 2009 Sep; 219(1):17-23. PubMed ID: 19713680
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Class II histone deacetylases act as signal-responsive repressors of cardiac hypertrophy.
    Zhang CL; McKinsey TA; Chang S; Antos CL; Hill JA; Olson EN
    Cell; 2002 Aug; 110(4):479-88. PubMed ID: 12202037
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Emodin and emodin-rich rhubarb inhibits histone deacetylase (HDAC) activity and cardiac myocyte hypertrophy.
    Evans LW; Bender A; Burnett L; Godoy L; Shen Y; Staten D; Zhou T; Angermann JE; Ferguson BS
    J Nutr Biochem; 2020 May; 79():108339. PubMed ID: 32007664
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Non-sirtuin histone deacetylases in the control of cardiac aging.
    Ferguson BS; McKinsey TA
    J Mol Cell Cardiol; 2015 Jun; 83():14-20. PubMed ID: 25791169
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Inpp5f is a polyphosphoinositide phosphatase that regulates cardiac hypertrophic responsiveness.
    Zhu W; Trivedi CM; Zhou D; Yuan L; Lu MM; Epstein JA
    Circ Res; 2009 Dec; 105(12):1240-7. PubMed ID: 19875726
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Estrogen regulates histone deacetylases to prevent cardiac hypertrophy.
    Pedram A; Razandi M; Narayanan R; Dalton JT; McKinsey TA; Levin ER
    Mol Biol Cell; 2013 Dec; 24(24):3805-18. PubMed ID: 24152730
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Regulation of acetylation of histone deacetylase 2 by p300/CBP-associated factor/histone deacetylase 5 in the development of cardiac hypertrophy.
    Eom GH; Nam YS; Oh JG; Choe N; Min HK; Yoo EK; Kang G; Nguyen VH; Min JJ; Kim JK; Lee IK; Bassel-Duby R; Olson EN; Park WJ; Kook H
    Circ Res; 2014 Mar; 114(7):1133-43. PubMed ID: 24526703
    [TBL] [Abstract][Full Text] [Related]  

  • 19. miR-21-3p regulates cardiac hypertrophic response by targeting histone deacetylase-8.
    Yan M; Chen C; Gong W; Yin Z; Zhou L; Chaugai S; Wang DW
    Cardiovasc Res; 2015 Mar; 105(3):340-52. PubMed ID: 25504627
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Type-specific roles of histone deacetylase (HDAC) overexpression in ovarian carcinoma: HDAC1 enhances cell proliferation and HDAC3 stimulates cell migration with downregulation of E-cadherin.
    Hayashi A; Horiuchi A; Kikuchi N; Hayashi T; Fuseya C; Suzuki A; Konishi I; Shiozawa T
    Int J Cancer; 2010 Sep; 127(6):1332-46. PubMed ID: 20049841
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.